Susquehanna International Group, LLP Rani Therapeutics Holdings, Inc. Call Options Transaction History

Susquehanna International Group, LLP

  • $688 Billion
  • Q2 2025

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$0.48 - $1.39 $3,648 - $10,564
-7,600 Reduced 33.04%
15,400 $7,000
Q1 2025

May 14, 2025
SELL
$1.25 - $1.85 $22,125 - $32,745
-17,700 Reduced 43.49%
23,000 $28,000
Q4 2024

Feb 14, 2025
BUY
$1.3 - $3.18 $52,910 - $129,426
40,700 New
40,700 $55,000

Others Institutions Holding RANI

# of Institutions
45
Shares Held
6.28M
Call Options Held
29.4K
Put Options Held
0
View Full List

About Rani Therapeutics Holdings, Inc.

RANI Quotes by TradingView
  • Ticker RANI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,492,000
  • Market Cap $11.8M
  • Description
  • Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...
More about RANI
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email